GDF2 and neoplasm: TGF-β signaling participates in tumor lymphangiogenesis (Oka, et al., 2008; Pak, et al., 2019) and inhibition of BMP9 by small-molecule compounds inhibits tumor lymphangiogenesis (Yoshimatsu, et al., 2013).